Patents by Inventor Paul A. Lyon
Paul A. Lyon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240263280Abstract: This invention relates to a magnesium alloy comprising: (a) 1.32-1.8 w1% Gd, (b) 2-3.6 w1% Nd, (c) 0.55-0.7 w1% Zr, (d) 0.20-0.40 w1% Zn, and (d) at least 85 wi % Mg, wherein the ratio of Gd:Nd (wt %) is 0.40-0.63. The invention also relates to an aircraft component comprising the magnesium alloy, as well as a to a method for producing the magnesium alloy.Type: ApplicationFiled: August 12, 2022Publication date: August 8, 2024Inventors: Matthew MURPHY, Paul LYON, Ismet SYED, Gabriella HORAN
-
Patent number: 11079098Abstract: A light assembly includes a substantially closed housing, a light source, a thermoelectric device, and a moisture expulsion device. The housing is defines a chamber, and includes a lens. The light source is adapted to direct light from the chamber and through the lens. The thermoelectric device includes a cold side and a hot side. The cold side is adapted to form condensation from moisture in the chamber. The moisture expulsion device includes a first segment in contact with the hot side and adapted to receive thermal heat from the hot side, and a second segment in contact with the first segment and exposed to an external environment for dissipation of moisture. The second segment is adapted to receive thermal heat from the first segment, and condensate from the cold side.Type: GrantFiled: March 24, 2020Date of Patent: August 3, 2021Assignee: VARROC LIGHTING SYSTEMS, S.R.O.Inventors: Dylan Schickel, Paul Lyon
-
Patent number: 11041206Abstract: The present invention provides a method of assessing whether an individual is at high risk or low risk of inflammatory bowel disease (IBD) progression by determining the expression level of two or more genes in a whole blood sample. Also provided are methods for treating IBD in an individual who is determined to be at high risk or low risk for IBD progression, and kits for assessing whether an individual is at high risk or low risk for IBD progression. Arrays, and methods of providing arrays, of patient-identified selected gene expression products from a whole blood sample of a patient are also provided.Type: GrantFiled: July 5, 2017Date of Patent: June 22, 2021Assignee: Cambridge Enterprise LimitedInventors: Paul A. Lyons, Kenneth G. C. Smith, Eoin F. McKinney, Daniele Biasci, James Lee
-
Patent number: 10910849Abstract: A charging method includes the following operations: charging an auxiliary power source and at least one charging power source simultaneously, in which a power demand of the auxiliary power source is a first consideration, and a power demand of the at least one charging power source is a second consideration; detecting an auxiliary current value of the auxiliary power source and a total charging current value of the at least one charging power source; and stopping charging the auxiliary power source when a sum of the auxiliary current value and the total charging current value is greater than a current threshold value.Type: GrantFiled: April 29, 2018Date of Patent: February 2, 2021Assignee: AVER INFORMATION INC.Inventors: Jay Paul Lyons, Cheng-Che Hsieh, Chi-Fa Hsu, Chao-Hung Chang, Lien-Kai Chou
-
Publication number: 20210015271Abstract: A retracting toy box assembly includes a box for storing toys, and the box has a track that is integrated therein. A spool is slidably coupled to the track, and the spool is positionable between a stored position and a deployed position. The spool is biased to rotate in a first direction and the spool is urgeable to rotate in a second direction. A mat is wrapped around the spool. The mat is unwrapped from the spool and extends forwardly from the box when the spool is positioned in the deployed position. In this way the mat can lie on the floor and toys can be positioned on the mat. Moreover, the mat can be lifted by a caregiver thereby facilitating all of the toys on the mat to be subsequently deposited in the box. In this way the mat assists the caregiver with putting the toys away.Type: ApplicationFiled: July 18, 2019Publication date: January 21, 2021Inventor: Paul Lyons
-
Patent number: 10640829Abstract: The present invention provides a method of assessing whether an individual is at high risk or low risk of inflammatory bowel disease (IBD) progression by determining the expression level of two or more genes in a whole blood sample. Also provided are methods for treating IBD in an individual who is determined to be at high risk or low risk for IBD progression, and kits for assessing whether an individual is at high risk or low risk for IBD progression. Arrays, and methods of providing arrays, of patient-identified selected gene expression products from a whole blood sample of a patient are also provided.Type: GrantFiled: October 12, 2018Date of Patent: May 5, 2020Assignee: CAMBRIDGE ENTERPRISE LIMITEDInventors: Paul A. Lyons, Kenneth G. C. Smith, Eoin F. McKinney, Daniele Biasci, James Lee
-
Patent number: 10424949Abstract: A storage device includes a base and a plurality of wire management modules. Each of the wire management modules includes a partition and a pivotal member. The partition is disposed to the base and has a supporting surface and a wire management groove. The supporting surface is located at the partition. The wire management groove is located at the supporting surface for accommodating wire. The pivotal member includes a fastening part and a pivotal part. The pivotal part is pivoted on the partition for a fastening position and a releasing position. When the pivotal member is at the fastening position, the fastening part covers the supporting surface for fastening wire between the surface and the fastening part. When the pivotal member is at the releasing position, the fastening part is spaced apart from the surface for releasing wire. The partitions and the base together form accommodation spaces.Type: GrantFiled: April 13, 2016Date of Patent: September 24, 2019Assignee: AVER INFORMATION INC.Inventors: Shu-Chen Chen, Hui-Lun Hung, Christopher Yen, Jay Paul Lyons
-
Publication number: 20190284531Abstract: The application relates to methods of assessing whether an individual has an exhausted CD8+ T cell or lack of CD4+ T cell costimulation phenotype, and the use of such methods in determining an individual's risk of autoimmune disease progression, progression of a chronic infection, not responding to a treatment for a chronic infection, not mounting an effective immune response to vaccination, infection-associated immunopathology, transplant rejection, or cancer progression.Type: ApplicationFiled: May 24, 2019Publication date: September 19, 2019Inventors: Kenneth G.C. Smith, Paul A. Lyons, Eoin F. McKinney
-
Publication number: 20190064234Abstract: Electrical data is gathered by a portable electrical energy consumption diagnostic device at a site. Each device is electrically connected into a respective electrical switchboard. One or more slave portable electrical energy consumption diagnostic devices can be connected to other switchboards at the same respective sites or other sites and communicates with a respective master device. Communication between master and slave devices is preferably wireless communication via a micro-network. Each master device communicates wirelessly electrical data obtained via the switchboard to a remote data collection server. The system identifies one or more electrical use or load features or characteristics and/or one or more electrical signature features of one or more electrical devices connected to an electrical circuit. One or more electrical devices is/are connected to an electrical circuit. Any electrical device connected to the circuit can be monitored and its electrical characteristics can be assessed.Type: ApplicationFiled: March 3, 2017Publication date: February 28, 2019Inventor: Paul LYONS
-
Patent number: 10202651Abstract: The present invention provides a method of assessing whether an individual is at high risk or low risk of inflammatory bowel disease (IBD) progression by determining the expression level of two or more genes in a whole blood sample. Also provided are methods for treating IBD in an individual who is determined to be at high risk or low risk for IBD progression, and kits for assessing whether an individual is at high risk or low risk for IBD progression. Arrays, and methods of providing arrays, of patient-identified selected gene expression products from a whole blood sample of a patient are also provided.Type: GrantFiled: July 17, 2017Date of Patent: February 12, 2019Assignee: Cambridge Enterprise LimitedInventors: Paul A. Lyons, Kenneth G. C. Smith, Eoin F. McKinney, Daniele Biasci, James Lee
-
Publication number: 20190032140Abstract: The present invention provides a method of assessing whether an individual is at high risk or low risk of inflammatory bowel disease (IBD) progression by determining the expression level of two or more genes in a whole blood sample. Also provided are methods for treating IBD in an individual who is determined to be at high risk or low risk for IBD progression, and kits for assessing whether an individual is at high risk or low risk for IBD progression. Arrays, and methods of providing arrays, of patient-identified selected gene expression products from a whole blood sample of a patient are also provided.Type: ApplicationFiled: October 12, 2018Publication date: January 31, 2019Inventors: Paul A. Lyons, Kenneth G.C. Smith, Eoin F. McKinney, Daniele Biasci, James Lee
-
Publication number: 20180316199Abstract: A charging method includes the following operations: charging an auxiliary power source and at least one charging power source simultaneously, in which a power demand of the auxiliary power source is a first consideration, and a power demand of the at least one charging power source is a second consideration; detecting an auxiliary current value of the auxiliary power source and a total charging current value of the at least one charging power source; and stopping charging the auxiliary power source when a sum of the auxiliary current value and the total charging current value is greater than a current threshold value.Type: ApplicationFiled: April 29, 2018Publication date: November 1, 2018Inventors: Jay Paul LYONS, Cheng-Che HSIEH, Chi-Fa HSU, Chao-Hung CHANG, Lien-Kai CHOU
-
Patent number: 9920402Abstract: Magnesium alloys which possess good processability and/or ductility while retaining good resistance to corrosion and/or degradation comprising Y: 0-10% by weight, Nd: 0-5% by weight, wherein the total of Y+Nd is at least 0.05% by weight, one or more heavy rare earths selected from Ho, Lu, Tm and Tb in a total amount of above 0.5% and no more than 5.5% by weight, Gd: 0-3.0% by weight, and Sm: 0-0.2% by weight. The alloy optionally includes one or more of: Dy: 0-8% by weight; Zr: 0-1.2% by weight; Al: 0-7.5% by weight; Zn and/or Mn: 0-2% by weight in total; Sc: 0-15% by weight; In: 0-15% by weight; Ca: 0-3% by weight; Er up to 5.5% by weight, provided that the total of Er, Ho, Lu, Tm and Tb is no more than 5.5% by weight; and one or more rare earths and heavy rare earths other than Y, Nd, Ho, Lu, Tm, Tb, Dy, Gd and Er in a total amount of up to 0.5% by weight; the balance being magnesium and incidental impurities up to a total of 0.3% by weight.Type: GrantFiled: March 23, 2011Date of Patent: March 20, 2018Assignee: Magnesium Elektron LimitedInventor: Paul Lyon
-
Publication number: 20180066228Abstract: The application relates to methods of assessing whether an individual has an exhausted CD8+ T cell or lack of CD4+ T cell costimulation phenotype, and the use of such methods in determining an individual's risk of autoimmune disease progression, progression of a chronic infection, not responding to a treatment for a chronic infection, not mounting an effective immune response to vaccination, infection-associated immunopathology, transplant rejection, or cancer progression.Type: ApplicationFiled: November 15, 2017Publication date: March 8, 2018Inventors: Kenneth G.C. Smith, Paul A. Lyons, Eoin F. McKinney
-
Patent number: 9874890Abstract: A portable electrical energy consumption diagnostic device 10 connects to electrical systems to acquire and analyze electrical data. The device has an onboard power supply 12, an energy monitoring means 14, a mini PC 16, a modem/router 18, CT adaptors 20 and an interface 22, all housed in a portable container 24, such as a hard case. The device 10 is connected to external electrical connector(s) (CT inputs) 26, 32 to temporarily connect the device to an electrical supply of electrical equipment. Electrical data acquisition means and an onboard electrical data processing means determine electrical consumption characteristics of monitored equipment over a period of time, such as lighting, air conditioning, elevators, pumps, motors etc. Optional transmission means transmits the acquired electrical data to a remote electrical data processor for remote electrical data processing. The onboard or remote data processor generating report data relating to the electrical energy consumption.Type: GrantFiled: October 4, 2013Date of Patent: January 23, 2018Assignee: ECOCENTRIC ENERGY PTY LTDInventor: Paul Lyons
-
Publication number: 20180010187Abstract: The present invention provides a method of assessing whether an individual is at high risk or low risk of inflammatory bowel disease (IBD) progression by determining the expression level of two or more genes in a whole blood sample. Also provided are methods for treating IBD in an individual who is determined to be at high risk or low risk for IBD progression, and kits for assessing whether an individual is at high risk or low risk for IBD progression. Arrays, and methods of providing arrays, of patient-identified selected gene expression products from a whole blood sample of a patient are also provided.Type: ApplicationFiled: July 5, 2017Publication date: January 11, 2018Inventors: Paul A. Lyons, Kenneth G.C. Smith, Eoin F. McKinney, Daniele Biasci, James Lee
-
Publication number: 20180010189Abstract: The present invention provides a method of assessing whether an individual is at high risk or low risk of inflammatory bowel disease (IBD) progression by determining the expression level of two or more genes in a whole blood sample. Also provided are methods for treating IBD in an individual who is determined to be at high risk or low risk for IBD progression, and kits for assessing whether an individual is at high risk or low risk for IBD progression. Arrays, and methods of providing arrays, of patient-identified selected gene expression products from a whole blood sample of a patient are also provided.Type: ApplicationFiled: July 17, 2017Publication date: January 11, 2018Inventors: Paul A. Lyons, Kenneth G.C. Smith, Eoin F. McKinney, Daniele Biasci, James Lee
-
Publication number: 20170155260Abstract: A storage device includes a base and a plurality of wire management modules. Each of the wire management modules includes a partition and a pivotal member. The partition is disposed to the base and has a supporting surface and a wire management groove. The supporting surface is located at the partition. The wire management groove is located at the supporting surface for accommodating wire. The pivotal member includes a fastening part and a pivotal part. The pivotal part is pivoted on the partition for a fastening position and a releasing position. When the pivotal member is at the fastening position, the fastening part covers the supporting surface for fastening wire between the surface and the fastening part. When the pivotal member is at the releasing position, the fastening part is spaced apart from the surface for releasing wire. The partitions and the base together form accommodation spaces.Type: ApplicationFiled: April 13, 2016Publication date: June 1, 2017Inventors: Shu-Chen CHEN, Hui-Lun HUNG, Christopher Yen, Jay Paul LYONS
-
Publication number: 20150234406Abstract: A portable electrical energy consumption diagnostic device 10 connects to electrical systems to acquire and analyse electrical data. The device has an onboard power supply 12, an energy monitoring means 14, a mini PC 16, a modem/router 18, CT adaptors 20 and an interface 22, all housed in a portable container 24, such as a hard case. The device 10 is connected to external electrical connector(s) (CT inputs) 26, 32 to temporarily connect the device to an electrical supply of electrical equipment. Electrical data acquisition means and an onboard electrical data processing means determine electrical consumption characteristics of monitored equipment over a period of time, such as lighting, air conditioning, elevators, pumps, motors etc. Optional transmission means transmits the acquired electrical data to a remote electrical data processor for remote electrical data processing. The onboard or remote data processor generating report data relating to the electrical energy consumption.Type: ApplicationFiled: October 4, 2013Publication date: August 20, 2015Applicant: ECOCENTRIC ENERGY PTY LTDInventor: Paul Lyons
-
Patent number: 9017604Abstract: Magnesium alloys containing: Y: 2.0-6.0% by weight Nd: 0-4.0% by weight Gd: 0-5.5% by weight Dy: 0-5.5% by weight Er: 0-5.5% by weight Zr: 0.05-1.0% by weight Zn+Mn: <0.11% by weight, optionally other rare earths and heavy rare earths, the balance being magnesium and incidental impurities and the total content of Gd, Dy and Er is in the range of 0.3-12% by weight, wherein either the alloy contains low amounts of Yb and Sm and exhibits a corrosion rate as measured according to ASTM B 117 of less than 30 Mpy, and/or the area percentage of any precipitated particles arising when the alloy is processed having an average particle size greater than 1 [mu]m and less than 15 [mu]m is less than 3%.Type: GrantFiled: September 30, 2009Date of Patent: April 28, 2015Assignee: Magnesium Elektron LimitedInventors: Paul Lyon, Ismet Syed, Anthony James Boden, Kenneth Savage